Alendronate should not be used in: * Acute inflammations of the gastrointestinal tract (esophagitis, gastritis, ulcerations) * Clinically manifested osteomalacia * Certain malformations and malfunctions of the esophagus (strictures, achalasia) * Inability to stand, walk, or sit for 30 minutes after oral administration * Renal impairment or chronic kidney disease as evidenced by a creatinine clearance below 30ml/min * Hypersensitivity to alendronate or another ingredient in the product * Hypocalcemia * Pregnancy and breastfeeding * Patients below 18 yrs. of age, as no clinical data exists for this population
Alendronic acid
Medronic acid
Risedronic acid
Pamidronic acid
Zoledronic acid
Etidronic acid
Ibandronic acid
Denosumab